Assertio Holdings logo
Assertio Holdings ASRT
€ 10.48 2.4%

Quartalsbericht 2025-Q3
hinzugefügt 10.11.2025

report update icon

Assertio Holdings Langfristiger Schuldenstrom 2011-2026 | ASRT

Langfristiger Schuldenstrom Jährlich Assertio Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
928 K 401 K 1.98 M 2.68 M - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
2.68 M 401 K 1.5 M

Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
4.36 M - - $ 754 M usaUSA
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
5.36 M - 7.5 % $ 6.35 M usaUSA
Catalent Catalent
CTLT
13 M - - $ 11.5 B usaUSA
Adamis Pharmaceuticals Corporation Adamis Pharmaceuticals Corporation
ADMP
343 K - 0.86 % $ 117 M usaUSA
DURECT Corporation DURECT Corporation
DRRX
1.38 M - - $ 50.1 M usaUSA
Canopy Growth Corporation Canopy Growth Corporation
CGC
7.46 M $ 1.12 5.19 % $ 120 M canadaCanada
Endo International plc Endo International plc
ENDP
956 K - - $ 28.9 M irlandaIrlanda
Agile Therapeutics Agile Therapeutics
AGRX
366 K - 10.11 % $ 58.2 M usaUSA
Evoke Pharma Evoke Pharma
EVOK
13.4 K - - $ 36.6 M usaUSA
Alimera Sciences Alimera Sciences
ALIM
634 K - - $ 142 M usaUSA
Evolus Evolus
EOLS
2.53 M $ 5.3 28.33 % $ 342 M usaUSA
Avadel Pharmaceuticals plc Avadel Pharmaceuticals plc
AVDL
582 K - - $ 2.06 B franceFrance
Harrow Health Harrow Health
HROW
887 K $ 40.19 4.11 % $ 1.48 B usaUSA
Jupiter Wellness Jupiter Wellness
JUPW
213 K - - $ 33.6 M usaUSA
China Pharma Holdings China Pharma Holdings
CPHI
39.3 K $ 0.57 4.45 % $ 9.95 M chinaChina
Cumberland Pharmaceuticals Cumberland Pharmaceuticals
CPIX
357 K $ 4.43 -3.17 % $ 62.3 M usaUSA
Calliditas Therapeutics AB (publ) Calliditas Therapeutics AB (publ)
CALT
3.91 M - -0.1 % $ 2.03 B schwedenSchweden
HEXO Corp. HEXO Corp.
HEXO
914 K - 2.45 % $ 38.1 M canadaCanada
Neoleukin Therapeutics Neoleukin Therapeutics
NLTX
2.56 M - - $ 193 M canadaCanada
Aurora Cannabis Aurora Cannabis
ACB
5.38 M $ 3.7 6.18 % $ 86.3 M canadaCanada
Athenex Athenex
ATNX
2.09 M - -23.39 % $ 1.76 M usaUSA
Organogenesis Holdings Organogenesis Holdings
ORGO
4.27 M $ 2.99 4.01 % $ 394 M usaUSA
Emergent BioSolutions Emergent BioSolutions
EBS
3.5 M $ 8.95 0.34 % $ 458 M usaUSA
ProPhase Labs ProPhase Labs
PRPH
301 K - - $ 5.07 M usaUSA
Radius Health Radius Health
RDUS
613 K - - $ 1.42 B usaUSA
Rockwell Medical Rockwell Medical
RMTI
1.38 M $ 0.9 0.09 % $ 21 M usaUSA
Bausch Health Companies Bausch Health Companies
BHC
61 M $ 5.6 -2.36 % $ 2.04 B canadaCanada
Lannett Company Lannett Company
LCI
2.06 M - 1.15 % $ 7.11 M usaUSA
Eagle Pharmaceuticals Eagle Pharmaceuticals
EGRX
1.53 M - -39.89 % $ 27.7 M usaUSA
Sundial Growers Sundial Growers
SNDL
34.3 M $ 1.55 0.98 % $ 3.37 M canadaCanada
OrganiGram Holdings OrganiGram Holdings
OGI
1.03 M $ 1.4 2.41 % $ 402 M canadaCanada
Perrigo Company plc Perrigo Company plc
PRGO
25.7 M $ 11.51 1.1 % $ 1.59 B usaUSA
TherapeuticsMD TherapeuticsMD
TXMD
1.47 M $ 2.32 4.5 % $ 24.2 M usaUSA
Pacira BioSciences Pacira BioSciences
PCRX
8.89 M $ 22.46 1.63 % $ 1.04 B usaUSA
PetIQ PetIQ
PETQ
7.61 M - 1.64 % $ 400 M usaUSA
OptiNose OptiNose
OPTN
911 K - - $ 1.08 B usaUSA
Veru Veru
VERU
1.07 M $ 2.63 4.36 % $ 355 M usaUSA
PLx Pharma PLx Pharma
PLXP
622 K - -27.8 % $ 2.56 M usaUSA
Viatris Viatris
VTRS
80.6 M $ 14.93 0.24 % $ 17.9 B usaUSA
Recro Pharma Recro Pharma
REPH
1.1 M - -4.76 % $ 65.3 M usaUSA
cbdMD cbdMD
YCBD
98.7 K $ 0.85 8.87 % $ 3.67 M usaUSA
SCYNEXIS SCYNEXIS
SCYX
340 K $ 0.73 -2.82 % $ 34.9 M usaUSA
Solid Biosciences Solid Biosciences
SLDB
1.79 M $ 6.14 2.94 % $ 251 M usaUSA
Sonoma Pharmaceuticals Sonoma Pharmaceuticals
SNOA
58 K $ 2.73 -0.91 % $ 3.39 M usaUSA
Tricida Tricida
TCDA
2.74 M - - $ 3.25 M usaUSA
Tilray Tilray
TLRY
2.47 M $ 7.56 2.65 % $ 4.67 B canadaCanada
Zynerba Pharmaceuticals Zynerba Pharmaceuticals
ZYNE
215 K - - $ 55.5 M usaUSA